Released on = May 9, 2007, 4:13 am

Press Release Author = Shushmul Maheshwari

Industry = Biotech

Press Release Summary = Biotechnology firms in the US have shown record growth
during the year 2006 through increased alliance with global drug makers.

Press Release Body = Year 2006 remained extraordinarily good for the US
biotechnology firms. The firms were able to deliver rapid growth in revenues and
earn huge profits. Biotechnology firms in US raised US$ 27.9 Billion in loans and
investments in this year, maximum since 2000. This reflected the increasing
alliances with drug makers of global industry.

Financings, public offerings, and revenues all showed remarkable increase as the
biotechnology firms in US went on to strengthen their position as innovation engines
in pharmaceutical sector, as per Ernst & Young - accounting & consulting firm
– in their annual report card on this industry.

Currently, there’re 52 profitable biotechnology firms. A new genre of firms is
joining biotechnology giants, such as Genentech and Amgen, and this has successfully
propelled drugs through to the regulatory approval, as per Gautam Jaggi, US based
analyst for Ernst & Young Global Health Sciences.

Above 4,000 biotechnology firms are into the business of manipulating cells and
genes. They are manipulated largely for developing drugs for arthritis, cancer, and
other diseases. Older makers of drug have paid to formulate alliances with biotechs,
after depending on chemistry for developing products.

Globally, revenues from biotechnology exceeded US$ 70 Billion for the 1st time as
Europe and Canada also enjoyed double digit growth. Venture funding throughout the
world reached a record US$ 5.4 Billion, also total financing registered a growth of
42% to reach US $27.9 Billion. Value of biotechnology market globally is expected to
be US$ 226.1 Billion by the year 2010.

According to RNCOS report “US Biotech Market Analysis”, “In 2005,
total revenues generated by the US biotechnology market reached US$ 68.6 Billion,
representing a CAGR of 15.16% (between 2001 and 2005). However the industry is
expected to generate US$ 131.8 Billion in revenues towards the end of 2010.”

This research report on “US Biotech Market Analysis” provides extensive
research and objective analysis of the Biotechnology industry in US. This report
helps clients in analyzing the opportunities critical to the growth of The
Biotechnology industry in US. Key issues addressed are: major market trends in the
US Biotechnology industry, opportunities and challenges before the Biotechnology
industry, etc.

About RNCOS E-Services Pvt Ltd.:

RNCOS, incorporated in the year 2002, is an industry research firm. It has a team of
industry experts who analyze data collected from credible sources. They provide
industry insights and analysis that helps corporations to take timely and accurate
business decision in today\'s globally competitive environment.

For more information visit: http://www.rncos.com/Report/IM0300.htm
Current Industry News: http://www.rncos.com/blog



Web Site = http://www.rncos.com

Contact Details = RNCOS E-Services Pvt Ltd.
Shushmul Maheshwari
Head of Business Development
29, 1st Floor, Patparganj Industrial Area, Delhi 92
91-11-4214-1229
info@rncos.com